. Thus, CK2 may have the capacity to differentially regulate U1 and U6 transcription even though SNAP C is universally utilized for human snRNA gene transcription.Protein kinase CK2 is an important regulator of cellular growth (1-4), and abnormal CK2 activity may contribute to tumor progression (5). CK2 is a tetrameric enzyme composed of two catalytic subunits, ␣ and ␣Ј, and two copies of the regulatory  subunit (6). One role for CK2 is to function as a regulatory protein that controls gene transcription. For example, general RNA synthesis in yeast is impaired when a temperature-sensitive mutant of the CK2 ␣Ј subunit is shifted to a restrictive temperature (7). This decline in total RNA synthesis also suggests that expression of highly transcribed genes encoding ribosomal (r), transfer (t), and small nuclear RNA (snRNA) 1 is sensitive to levels of functional CK2. In yeast CK2 is important for active RNA polymerase III transcription (8) and yet, paradoxically, CK2 has been proposed to be the terminal effector in a DNA damage response pathway that represses RNA polymerase III transcription (9). In humans, CK2 exhibits differential effects on gene transcription during the cell cycle. During mitosis, CK2 inhibits RNA polymerase III transcription, whereas at other stages CK2 can stimulate transcription (10). The nature of the regulation is dictated by CK2 target selection. One key target for CK2 is the general transcription factor TFIIIB (11-13). There are at least two versions of human TFIIIB that function for transcription of distinct classes of genes (14). The Brf1⅐TFIIIB complex functions for 5 S rRNA and tRNA transcription and is composed of the TATA-box-binding protein (TBP) and the TBP-associated factors, Bdp1 and Brf1. The Brf2⅐TFIIIB complex functions for U6 snRNA transcription and is composed of TBP plus Bdp1 but Brf2 instead of Brf1. Brf1⅐TFIIIB phosphorylation during M phase results in the selective release of Bdp1 from tRNA promoters (15). Hernandez and co-workers (10) further demonstrated that Bdp1 is the critical CK2 target within Brf2⅐TFIIIB for mitotic repression of U6 transcription. Because Bdp1 is a shared component of both TFIIIB complexes, CK2 may target this factor to repress global RNA polymerase III transcription. However, CK2 inhibitors also interfere with Brf1⅐TFIIIB binding to the TFIIIC complex (12), which itself recognizes intragenic promoter elements of 5 S rRNA and tRNA genes, suggesting that CK2 also has a stimulatory role in RNA polymerase III transcription through enhanced preinitiation complex assembly. Consistent with this positive role, CK2 can also activate RNA polymerase III transcription in human cells (12) and in this process may additionally phosphorylate RNA polymerase III itself (13). Together, these data point to an important but complex role for CK2 control of RNA polymerase III transcription.Human U6 snRNA genes are interesting because they are transcribed by RNA polymerase III and yet their promoters are similar to other snRNA genes, such as U1 and U2, which are tran...